300 participants
Yuflyma® (Adalimumab), Patient Experience After Switching
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2022-06-22
- Start Date:
- 2022-06-03
- Completion:
- 2022-12-31
Conditions
- Rheumatoid Arthritis
- Ankylosing Spondylarthritis
- Axial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis
- Psoriatic Arthritis
- Crohn Disease
- Ulcerative Colitis
Interventions
- DRUG
No Results Yet